Meloxicam and Urinary frequency aggravated - a phase IV clinical study of FDA data
Urinary frequency aggravated is reported only by a few people who take Meloxicam.
The phase IV clinical study analyzes which people take Meloxicam and have Urinary frequency aggravated. It is created by eHealthMe based on reports of 49,760 people who have side effects while taking Meloxicam from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
49,760 people reported to have side effects when taking Meloxicam.
Among them, 5 people (0.01%) have Urinary frequency aggravated.
What is Meloxicam?
Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 52,561 Meloxicam users for its effectiveness, alternative drugs and more.
What is Urinary frequency aggravated?
Urinary frequency aggravated is found to be associated with 341 drugs and 44 conditions by eHealthMe.
Number of Meloxicam and Urinary frequency aggravated reports submitted per year:
Gender of people who have Urinary frequency aggravated when taking Meloxicam *:
- female: 0.0 %
- male: 100 %
Common drugs people take besides Meloxicam *:
- Nifedipine: 5 people, 100.00%
- Gabapentin: 5 people, 100.00%
- Vicodin: 4 people, 80.00%
- Simvastatin: 4 people, 80.00%
- Plavix: 4 people, 80.00%
- Normodyne: 4 people, 80.00%
- Lasix: 4 people, 80.00%
- Glucotrol: 4 people, 80.00%
- Gemfibrozil: 4 people, 80.00%
- Detrol La: 4 people, 80.00%
Common side effects people have besides Urinary frequency aggravated *:
- Muscle Aches (muscle pain): 5 people, 100.00%
- Confusion: 5 people, 100.00%
- Joint Pain: 5 people, 100.00%
- Weakness: 5 people, 100.00%
- Haematuria (presence of blood in urine): 5 people, 100.00%
- Back Pain: 5 people, 100.00%
- Urine Flow Decreased: 5 people, 100.00%
- Urination - Excessive At Night: 5 people, 100.00%
- Enlarged Prostate: 5 people, 100.00%
- Dizziness (Excl Vertigo): 5 people, 100.00%
Common conditions people have *:
- High Blood Cholesterol: 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Meloxicam and have Urinary frequency aggravated?Check whether Urinary frequency aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Alternative drugs to, pros and cons of Meloxicam:
- Meloxicam (52,561 reports)
Urinary frequency aggravated treatments and more:
- Urinary frequency aggravated (58 reports)
COVID vaccines that are related to Urinary frequency aggravated:
- Urinary frequency aggravated in Moderna COVID Vaccine
- Urinary frequency aggravated in Pfizer BioNTech Covid Vaccine
- Urinary frequency aggravated in Johnson and Johnson Covid Vaccine
How severe was Urinary frequency aggravated and when was it recovered:
Expand to all the drugs that have ingredients of meloxicam:
Common drugs associated with Urinary frequency aggravated:
- Detrol la: 105 reports
- Lipitor: 137 reports
- Norvasc: 136 reports
- Prilosec: 115 reports
- Zoloft: 107 reports
All the drugs that are associated with Urinary frequency aggravated:
- Urinary frequency aggravated (341 drugs)
All the conditions that are associated with Urinary frequency aggravated:
- Urinary frequency aggravated (44 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.